Overexpression of the oncogene c-erbB-2 (HER2/neu) in ovarian cancer: a new prognostic factor (Q41461146)

1 October 2017

1 reference

title

Overexpression of the oncogene c-erbB-2 (HER2/neu) in ovarian cancer: a new prognostic factor (English)

1 reference

1 October 2017

1 reference

1 reference

Meden H

1

1 reference

1 October 2017

Kuhn W

series ordinal

2

1 reference

1 October 2017

language of work or name

1 reference

1 February 1997

1 reference

European Journal of Obstetrics Gynecology and Reproductive Biology

1 October 2017

published in

1 reference

1 October 2017

volume

71

1 reference

1 October 2017

issue

2

1 reference

1 October 2017

page(s)

173-179

1 reference

Prognostic significance of histologic classification and grading of epithelial malignancies of the ovary

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902630-9

7 January 2021

Oncogene amplification in tumor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902630-9

7 January 2021

The molecular genetics of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902630-9

7 January 2021

Genomic alterations of the c-myc protooncogene in relation to the overexpression of c-erbB2 and Ki-67 in human breast and cervix carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902630-9

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902630-9

7 January 2021

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902630-9

7 January 2021

The neu oncogene encodes an epidermal growth factor receptor-related protein

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902630-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902630-9

7 January 2021

Amplification of a novel v-erbB-related gene in a human mammary carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902630-9

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902630-9

7 January 2021

Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902630-9

7 January 2021

c-erbB2 expression in correlation to other biological parameters of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902630-9

7 January 2021

Overexpression of the oncogene c-erb B2 in primary ovarian cancer: evaluation of the prognostic value in a Cox proportional hazards multiple regression

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902630-9

7 January 2021

c-erbB-2 oncogene expression in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902630-9

7 January 2021

Elevated serum levels of a c-erbB-2 oncogene product in ovarian cancer patients and in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902630-9

7 January 2021

Tumor promoter and epidermal growth factor stimulate phosphorylation of the c-erbB-2 gene product in MKN-7 human adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902630-9

7 January 2021

Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902630-9

7 January 2021

Epidermal growth factor receptor expression in gynecological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902630-9

7 January 2021

The prognostic value of epidermal growth factor receptors, determined by both immunohistochemistry and ligand binding assays, in primary epithelial ovarian cancer: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902630-9

7 January 2021

Prognostic value of pS2 protein and receptors for epidermal growth factor (EGF-R), insulin-like growth factor-1 (IGF-1-R) and somatostatin (SS-R) in patients with breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902630-9

7 January 2021

High incidence of EGF receptor hyperproduction in esophageal squamous-cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902630-9

7 January 2021

p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902630-9

7 January 2021

10.1016/S0301-2115(96)02630-9

Identifiers

DOI

1 reference

1 October 2017

1 reference